2m 2m 2m 2m 2m 2m 2m
CRINETICS PHARMA (CRNX)
NASDAQ
$83.42-$0.25 (-0.30%)
Price as of Jul 14, 2026 5:35 AM EDT- $8.9BMarket Cap
- 153.39%1-Year Change
- BiotechnologyIndustry
CRINETICS PHARMA (CRNX)
$83.42-$0.25 (-0.30%)
Earnings Score
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -0 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -14.11% | ||
12-Month Momentum | 7.49% | ||
3-Month Risk Adjusted Momentum | -61.72% | ||
12-Month Risk Adjusted Momentum | 13.44% |
True Yield
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | CRNX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |